elbasvir

FDA yanks 'breakthrough' bragging rights to Merck's hep C combo
Fierce Biotech
Wed, 02/4/15 - 08:36 am
FDA
Merck
hepatitis C
grazoprevir
elbasvir
Merck speeds up drug-submission plans for Hep C, lung cancer -WSJ
Yahoo/Reuters
Mon, 01/12/15 - 08:22 am
Merck
hepatitis C
non-small cell lung cancer
Keytruda
grazoprevir
elbasvir
Merck’s Four-Week Hepatitis C Regimen Fails to Top Gilead
Bloomberg
Mon, 11/10/14 - 07:57 am
hepatitis C
Merck
Gilead Sciences
grazoprevir
elbasvir
Sovaldi